LONA
LeonaBio, Inc.
$8.67
-0.07 (-0.80%)
At close · Jul 8
Market Cap
$81.44M
Shares
9,393,514
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.67
Open$8.50
Day$8.13–8.89
52W$3.24–14.21
Avg vol 30d24K
Short int52K · 0.5% float · 2.9d
Short vol54%
Last earningsMay 7, 2026
DataSep 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+29%
above
Price vs 50-day avg
−5%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
49%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+33%
trailing
YTD return
+15%
this year
Relative strength
+25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $9 › 200d $7 — 50d above 200d
Institutional flow
Distributing
-5% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.55% of float · ▼ -8.8% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — 13F breadth
Squeeze score
60
elevated · 0–100
Fundamentals
EPS growth
+2%
Y/Y
Free cash flow
$-45.8M
Balance sheet
$69.3M
net cash
Quant / Vol
risk profile
Volatility
107%
annualized · 1-yr
Max drawdown
−43%
past year
ATR
8.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 6, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+29%
Bullish
Price vs 50-day avg
−5%
Bearish
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
49%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $9 › 200d $7 — 50d above 200d
Institutional flow
Distributing
-5% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.55% of float · ▼ -8.8% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $3
Now $9 · 49%
52-wk high $14
vs 200-day avg +29%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LONA
this stock
LeonaBio, Inc.
|
$81.44M | +14.5% | — | — | 0.5% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LONA | -5.7% | +0.9% | +32.6% | -5.7% | +14.5% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -5.5% | +0.1% | +25.1% | -5.5% | +5.2% |